• English
  • Dansk
Kontakt os


Rygards Alle 1
2900 Hellerup
Tlf: 3946 3600
Jura tlf: 3190 3600

Sekretariatets åbningstider


Mandag - torsdag 09.30 - 16.00
Fredag 09.30 - 14.00

På adressen

Mandag - torsdag 09.30 - 16.00
Fredag 09.30 - 14.00
Navn Stilling Telefon E-mail
Andreas Thilqvist Konsulent 39463626 at@pharmadanmark.dk
Anne Simonsen Regnskabsassistent 3946 3617 as@pharmadanmark.dk
Annette Meyer Økonomi- og administrationschef 39463639 am@pharmadanmark.dk
Arendse Veirø Jurist ​3946 3638 ave@pharmadanmark.dk
Bente Gade Chef for ledelsessekretariatet 39463621 bg@pharmadanmark.dk
Bo Ekkert Knudsen Juridisk chef, advokat 39463633 bek@pharmadanmark.dk
Carsten Mandrup Olsen Servicemedarbejder 39463608 co@pharmadanmark.dk
Casper Gad Advokat 39463627 cg@pharmadanmark.dk
Christian K. Thorsted Kommunikationschef 39463614 ckt@pharmadanmark.dk
Frederik Kragh Nielsen Politisk konsulent 39463636 fkn@pharmadanmark.dk
Iben Treebak ​Konsulent, Karriere & Udvikling 39463618 ibt@pharmadanmark.dk
Jeannette Petersen Assistent 39463607 jp@pharmadanmark.dk
Lotte Skovdal PA og arrangementskoordinator 39463609 lsk@pharmadanmark.dk
Malene Dalmark Espeland Kommunikationskonsulent 39463634 mde@pharmadanmark.dk
Marie Fog Lægemiddelfaglig konsulent 39463619 mf@pharmadanmark.dk
Natasia Lykkeholm Klausen Advokat 39463636 nlk@pharmadanmark.dk
Pressetelefon 21768404 redaktionen@pharmadanmark.dk
Rikke Løvig Simonsen Formand for Pharmadanmark 31240265 rls@pharmadanmark.dk
Robert Barrit Sørensen Jurist 39463635 rbs@pharmadanmark.dk
Sarah Piil Kommunikationskonsulent 39463637 ssp@pharmadanmark.dk
Susie Stærk Ekstrand Adm. direktør 30178865 se@pharmadanmark.dk
Trine Wesselhoff Public affairs chef 21455541 tw@pharmadanmark.dk
39 46 36 00
Du er her:
Hjem - Nyheder - EMA: Impressive Danish effort

EMA: Impressive Danish effort

EMA: Impressive Danish effort
23.11.2017 admin

Copenhagen was among the final three candidate cities, but was pipped at post by Amsterdam when the European Council made its decision on the relocation of the EMA on 20 November.

“Of course, we are frustrated that Copenhagen did not win the EMA. And that the EMA did not win Copenhagen. When all is said and done, I am sure that the excellent European partnership we have in place on ensuring and certifying pharmaceutical products for European citizens will continue from Amsterdam. But the fact that issues surrounding the important pan-European work in the field of pharmacy have now been settled is also very positive,” says Chairman of Pharmadanmark Rikke Løvig Simonsen.

She continues:

“It was impressive that Denmark and Copenhagen came so close – and this simply emphasises how strong our bid was and how highly regarded the Danish life sciences are internationally.”

A total of 19 countries submitted bids for the agency, but five hours before the vote three countries chose to withdraw from the race, namely Malta, Croatia and Ireland. Denmark won enough votes – in the company of Amsterdam and Milan – to progress to the second round of the ballot. This was where Denmark, unfortunately, lost out by just five votes.

Pharmadanmark was active in the Danish campaign to get the EMA to Copenhagen from the very beginning  – in partnership with the Municipality of Copenhagen, the Metropolitan Region, the Confederation of Danish Industry, the Danish Chamber of Commerce, Danish universities, the Danish Association of the Pharmaceutical Industry, Copenhagen Capacity, the Danish Medicines Agency, Greater Copenhagen and major pharmaceutical corporations such as LEO Pharma and Novo Nordisk. Lars Rebien Sørensen, former CEO of Novo Nordisk, worked as the Danish government’s special EMA emissary.

Rikke Løvig Simonsen is very happy with the collaborative work that was done on the campaign:

“Although we, unfortunately, did not win the EMA, the Danish campaign has contributed to consolidating partnerships in the Danish life sciences. Many different operators worked towards the same goal and that is something we will be able to build on. Basically, it is all about strengthening the Danish life sciences.”

14.03.2018 Redaktionen
Sammenbruddet i forhandlingerne om nye overenskomster på hele det offentlige område truer med at udvikle sig til strejke og lockout. Vi ved, at det giver anledning til mange spørgsmål hos vores...
12.03.2018 Redaktionen
Anette Green Nielsen, formand for Apotekssektoren i Pharmadanmark, har stor forståelse for de krav, som de offentligt ansatte i stat, kommuner og regioner stiller til nye overenskomster (OK18). ”De...
09.03.2018 Redaktionen
Netop nu trækker det alvorligt op til konflikt på det offentlige område. Forhandlingerne om nye offentlige overenskomster er brudt sammen, og både arbejdsgivere og lønmodtagere har varslet konflikt....
08.03.2018 Redaktionen
Regeringen har her til formiddag offentliggjort sin vækstplan for life science med 36 initiativer, som skal gøre Danmark til en førende life science-nation i Europa. Initiativerne tager udgangspunkt...
@ 2017 Pharmadenmark    CVR 65250314 Forside Aktuelt Forside Forside